Latest news with #AACI
Business Standard
02-07-2025
- Health
- Business Standard
Asian Institute of Medical Sciences honoured as Best Healthcare Brand 2025 by The Economic Times
VMPL Faridabad (Haryana) [India], July 2: The Asian Institute of Medical Sciences, a super-speciality hospital with a strong focus on advanced medical care, including 3D robotic surgery and a wide range of super specialities, has been named the Best Healthcare Brand 2025 by ET Now - The Economic Times Group. Dr. Ajeet Madhavrao Gopchade, Member of Parliament, Rajya Sabha presented the award to the Asian Hospital at the ET Now Best Brands Conclave for its role in shaping the future of healthcare in India. Asian has been recognized for its technology-driven treatment and consistent clinical excellence. "This recognition reflects Asian's dedication to providing advanced and compassionate healthcare to people, not just in Faridabad but across the region. The hospital has always stayed ahead by combining expert medical care with the latest technologies," said Dr. N. K. Pandey, Chairman & Managing Director, Asian Institute of Medical Sciences. Mr. Anupam Pandey, Director, Asian Institute of Medical Sciences. said, "This award is a moment of great pride for all of us at the Asian. It shows that our commitment to patient care, innovation, and ethics is being recognised at the national level. We remain dedicated to bringing them world-class healthcare with a personal touch." Mr. Anupam Pandey further said, we ensure that AIMS remains at the forefront of medical innovation and patient-centred care. Asian Institute of Medical Sciences has become a household name over the years, thanks to its top-tier services in areas like cancer treatment, heart and cardiac care, brain and spine surgery, liver and digestive diseases and orthopaedics. A major highlight of the hospital today is its 3D Advanced Minimal Access Robotic Surgery. This modern technique allows for extremely precise surgeries with smaller cuts, less pain, and faster healing. Adding to its technological edge, the Asian Hospital has recently introduced an AI-powered Robotic Knee Replacement system for minimally invasive procedures, high-precision robotic technology, and faster, safer recovery. This award follows another major achievement, where Asian was honoured with the "One of the Best Organisations to Work For in 2025" by ET Edge. Founded in 2010, the Asian Institute of Medical Sciences has since grown to become one of India's leading AACI, NABH, and NABL-accredited super specialty hospitals.
Bangkok Post
27-06-2025
- Health
- Bangkok Post
Thainakarin Earns AACI Accreditation for Oncology Excellence
Thainakarin Hospital has officially received certification from the American Accreditation Commission International (AACI) for Clinical Oncology Services Excellence—marking a significant milestone in the hospital's mission to become a leading specialised cancer care centre. The prestigious accreditation recognises Thainakarin's outstanding achievements in cancer care quality, patient safety, and comprehensive clinical systems. It affirms the hospital's dedication to delivering international-standard treatment while enhancing the quality of life for patients. As part of this commitment, Thainakarin has established the Thainakarin Precision Oncology Center (TPOC) to offer high-quality, convenient cancer care across a range of common cancers. In addition, the launch of a state-of-the-art Radiation Therapy Center enhances treatment efficiency, safety, and reliability—reinforcing public trust and expanding international patient outreach. The certification follows a rigorous assessment by AACI, led by Dr Somporn Khampong, Head Surveyor. The evaluation covered all aspects of Thainakarin's oncology operations, including clinical protocols, staff competence, and outcome-based care. Key leaders participated in the site assessment, including Clinical Prof Dr Thipchat Boonyaratpan, Hospital Director and Medical Director; Dr Pattarapol Kammultri, Director of Quality Management; and Dr Arkom Chiansilp, Director of the Oncology and Radiation Therapy Center. They were joined by physicians, nurses, and the hospital's multidisciplinary team, who shared insights into Thainakarin's integrated cancer care model. The AACI Clinical Excellence Oncology Services certification evaluates the entire cancer care ecosystem. Core assessment criteria include: Specialised clinical quality management in oncology Multidisciplinary patient-centred care Personalised treatment planning Chemotherapy risk and medication safety management Palliative care and effective communication Competency and continuous professional development Clinical outcome measurement and patient satisfaction This recognition underscores Thainakarin Hospital's position as a forward-thinking medical institution aligned with global healthcare standards, with a focus on both clinical excellence and holistic well-being. Vision Thainakarin Precision Oncology Center (TPOC) is committed to providing personalised, internationally accredited cancer care, supported by advanced medical technologies and focused on enhancing treatment value, service quality, and patient outcomes. Mission Deliver comprehensive cancer services—including screening, diagnosis, personalised treatment, rehabilitation, and prevention—aligned with NCCN Clinical Practice Guidelines. Provide exceptional treatment experiences that promote well-being and quality of life. Cultivate highly skilled, ethically driven oncology professionals. About AACI The American Accreditation Commission International (AACI) is a globally recognised healthcare accreditation organisation. Its mission is to promote safety, quality, and excellence in medical care across international settings, with a patient-centred approach at the core. Receiving AACI accreditation affirms that Thainakarin Hospital meets globally accepted service benchmarks and consistently delivers high-quality, compassionate care that meets the needs and expectations of both Thai and international patients.
Business Wire
22-05-2025
- Business
- Business Wire
Armada Acquisition Corp. II Announces Closing of $230 Million Initial Public Offering
PHILADELPHIA--(BUSINESS WIRE)--Armada Acquisition Corp. II (the 'Company' or 'AACI') announced today the closing of its initial public offering of 23,000,000 units, including a fully exercised over-allotment option, at $10.00 per unit. The offering resulted in gross proceeds to the Company of $230,000,000. The units began trading on the Nasdaq Global Market ('Nasdaq') on May 21, 2025 under the ticker symbol "AACIU." Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols 'AACI' and 'AACIW,' respectively. AACI is a special purpose acquisition company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition or business combination target in any business or industry, it intends to focus its search on businesses in the financial services ('FinTech'), Software-as-a-Service ('SaaS'), or generative artificial intelligence ('AI') industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals. AACI is led by Stephen P. Herbert, Chairman and Chief Executive Officer, Douglas M. Lurio, President, Chief Financial Officer and Director, Mohammad A. Khan, Director, Thomas (Tad) A. Decker, Director, and Celso L. White, Director. This is the same team that led Armada Acquisition Corp. I, a special purpose acquisition company that completed a business combination with Rezolve AI Limited in August 2024. Cohen & Company Capital Markets, a division of J.V.B. Financial Group LLC, acted as lead book-runner, and Northland Capital Markets acted as joint book-runner for the offering. DLA Piper LLP (US) served as US legal counsel for the Company, Ogier (Cayman) LLP served as Cayman Islands legal counsel for the Company, Loeb & Loeb LLP served as legal counsel for the underwriters, and CBIZ CPAs P.C. acted as the auditor. A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on May 20, 2025. The offering was made only by means of a prospectus. Copies of the final prospectus may be obtained by contacting Cohen & Company Capital Markets, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@ or Northland Securities, Inc., 150 South 5th Street, Suite 3300, Minneapolis, MN 55402. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward-Looking Statements This press release contains statements that constitute 'forward-looking statements,' including with respect to the anticipated use of net proceeds. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the offering filed with the SEC. Copies are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. About Armada Acquisition Corp. II The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. Although the Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, the Company intends to focus on a target in the financial services ('FinTech'), Software-as-a-Service ('SaaS'), or generative artificial intelligence ('AI') industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals. The Company was founded on October 3, 2024 and its executive offices are located in Philadelphia, PA.
Yahoo
21-05-2025
- Business
- Yahoo
Armada Acquisition Corp. II Announces Pricing of $200,000,000 Initial Public Offering
PHILADELPHIA, May 21, 2025--(BUSINESS WIRE)--Armada Acquisition Corp. II (the "Company" or "AACI") announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market ("Nasdaq") and trade under the ticker symbol "AACIU" beginning on May 21, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols "AACI" and "AACIW," respectively. AACI is a special purpose acquisition company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition or business combination target in any business or industry, it intends to focus its search on businesses in the financial services ("FinTech"), Software-as-a-Service ("SaaS"), or generative artificial intelligence ("AI") industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals. AACI is led by Stephen P. Herbert, Chairman and Chief Executive Officer and Director, Douglas M. Lurio, President, Chief Financial Officer and Director, Mohammad A. Khan, Director, Thomas (Tad) A. Decker, Director, and Celso L. White, Director. Cohen & Company Capital Markets, a division of J.V.B. Financial Group LLC, is acting as lead book-runner, and Northland Capital Markets is acting as joint book-runner for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments, if any. The offering is expected to close on May 22, 2025, subject to customary closing conditions. The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained by contacting Cohen & Company Capital Markets, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@ or Northland Securities, Inc., 150 South 5th Street, Suite 3300, Minneapolis, MN 55402. A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the "SEC") and was declared effective on May 20, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward-Looking Statements This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. About Armada Acquisition Corp. II The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. Although the Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, the Company intends to focus on a target in the financial services ("FinTech"), Software-as-a-Service ("SaaS"), or generative artificial intelligence ("AI") industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals. The Company was founded on October 3, 2024 and its executive offices are located in Philadelphia, PA. View source version on Contacts Investor Contact: Mike BishopBishop IR, LLCmike@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
21-05-2025
- Business
- Business Wire
Armada Acquisition Corp. II Announces Pricing of $200,000,000 Initial Public Offering
PHILADELPHIA--(BUSINESS WIRE)--Armada Acquisition Corp. II (the 'Company' or 'AACI') announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market ('Nasdaq') and trade under the ticker symbol "AACIU" beginning on May 21, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols 'AACI' and 'AACIW,' respectively. AACI is a special purpose acquisition company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition or business combination target in any business or industry, it intends to focus its search on businesses in the financial services ('FinTech'), Software-as-a-Service ('SaaS'), or generative artificial intelligence ('AI') industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals. AACI is led by Stephen P. Herbert, Chairman and Chief Executive Officer and Director, Douglas M. Lurio, President, Chief Financial Officer and Director, Mohammad A. Khan, Director, Thomas (Tad) A. Decker, Director, and Celso L. White, Director. Cohen & Company Capital Markets, a division of J.V.B. Financial Group LLC, is acting as lead book-runner, and Northland Capital Markets is acting as joint book-runner for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments, if any. The offering is expected to close on May 22, 2025, subject to customary closing conditions. The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained by contacting Cohen & Company Capital Markets, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@ or Northland Securities, Inc., 150 South 5th Street, Suite 3300, Minneapolis, MN 55402. A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the "SEC") and was declared effective on May 20, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward-Looking Statements This press release contains statements that constitute 'forward-looking statements,' including with respect to the proposed initial public offering and the anticipated use of net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. About Armada Acquisition Corp. II The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. Although the Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, the Company intends to focus on a target in the financial services ('FinTech'), Software-as-a-Service ('SaaS'), or generative artificial intelligence ('AI') industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals. The Company was founded on October 3, 2024 and its executive offices are located in Philadelphia, PA.
